| Date | Ticker | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | AMBARELLA INC | Ju Chi-Hong Senior VP, Systems & GM, Asia | sell | 2,155 | $54.14 | $117K |
| Mar 19, 2026 | Revolution Medicines, Inc. | Wang Xiaolin See Remarks | sell | 2,010 | $99.48 | $200K |
| Mar 19, 2026 | Phreesia, Inc. | Pale Fire Capital SE | buy | 303,300 | $11.20 | $3.40M$1M+ |
| Mar 19, 2026 | Phreesia, Inc. | Pale Fire Capital SE | buy | 519,196 | $11.15 | $5.79M$5M+ |
| Mar 19, 2026 | Phreesia, Inc. | Pale Fire Capital SE | buy | 780,009 | $11.69 | $9.12M$5M+ |
| Mar 19, 2026 | Revolution Medicines, Inc. | Wei Lin Chief Medical Officer | sell | 2,073 | $99.48 | $206K |
| Mar 19, 2026 | Revolution Medicines, Inc. | Kelsey Stephen Michael See Remarks | sell | 4,302 | $99.48 | $428K |
| Mar 19, 2026 | Revolution Medicines, Inc. | GOLDSMITH MARK A See Remarks | sell | 12,871 | $99.48 | $1.28M$1M+ |
| Mar 19, 2026 | RVMD👔 Revolution Medicines, Inc. | Horn Margaret A Chief Operating Officer | sell | 4,583 | $99.48 | $456K |
| Mar 19, 2026 | RVMD👔 Revolution Medicines, Inc. | Anders Jack Chief Financial Officer | sell | 2,753 | $99.48 | $274K |
| Mar 19, 2026 | RVMD👔 Revolution Medicines, Inc. | Cislini Jeff General Counsel | sell | 1,795 | $99.48 | $179K |
| Mar 19, 2026 | RVMD👔 Revolution Medicines, Inc. | Cislini Jeff General Counsel | sell | 1,163 | $97.44 | $113K |
| Mar 19, 2026 | TARS👔 Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri Chief Operating Officer | sell | 3,125 | $69.42 | $217K |
| Mar 19, 2026 | TARS👔 Tarsus Pharmaceuticals, Inc. | Azamian Bobak R. President/CEO and Board Chair | sell | 11,667 | $68.71 | $802K |
| Mar 19, 2026 | TARS👔 Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri Chief Operating Officer | sell | 3,610 | $68.71 | $248K |
| Mar 19, 2026 | TARS👔 Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri Chief Operating Officer | sell | 4,589 | $67.00 | $307K |
| Mar 19, 2026 | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz Chief Commercial Officer | sell | 4,286 | $69.42 | $298K |
| Mar 19, 2026 | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz Chief Commercial Officer | sell | 4,330 | $68.71 | $298K |
| Mar 19, 2026 | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz Chief Commercial Officer | sell | 4,440 | $67.00 | $297K |
| Mar 19, 2026 | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S See Remarks | sell | 2,111 | $69.42 | $147K |